Moderna (MRNA) Shares Could Rally '10-20%' as Morgan Stanley Expects Initial Flu Vaccine Data to be Positive

November 23, 2021 5:43 AM EST Send to a Friend
Morgan Stanley analyst Matthew Harrison is confident that Moderna (NASDAQ: MRNA) is likely to report positive initial data for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login